The patient comes first

Article

Ever wondered what it must be like for today's refractive surgeon, having to perform a job to the best of their ability whilst sometimes facing criticism for being "too commercial"? The refractive surgery industry has suffered its fair share of setbacks over recent years and certainly, some clinics have deservedly earned this criticism for not performing the job adequately.

If you treat your patient well and give them the correct support, both before and after surgery, your practice will inevitably gain a good reputation. Suddenly you will find prospective patients arriving at your surgery because their friend or their relative recommended you to them. Not only does this instil patient trust but it will also go towards securing the longevity of your practice. Isn't this how every business wants to operate?

This month I spoke with two inspirational Italian, refractive surgeons who are truly passionate about their trade. Please go to page 19 to find out what Roberto Pinelli and Paolo Fazio had to say about the issues relating to their industry today and how they are making progress towards improving the situation in their wonderful home country of Italy.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.